MRK
Merck & Co. · Health Care
1.7%
typical move (median |reaction| of last 8)
2026-10-29 pre · likely
next expected · estimated from pattern
12
scored events
Last eight reactions
2024-10-31 → 2026-08-04
| date | session | reaction | |move| | excess 5s | excess 20s |
|---|---|---|---|---|---|
| 2026-08-04 | pre | +0.2% | 0.2% | +1.9% | +18.3% |
| 2026-04-30 | pre | -1.7% | 1.7% | +1.0% | +3.5% |
| 2026-02-03 | pre | +2.2% | 2.2% | +0.7% | +4.4% |
| 2025-10-30 | pre | -0.3% | 0.3% | +0.9% | +21.0% |
| 2025-07-29 | pre | -1.7% | 1.7% | -1.2% | +1.2% |
| 2025-04-24 | pre | +1.4% | 1.4% | +2.1% | -9.2% |
| 2025-02-04 | pre | -9.1% | 9.1% | -5.2% | +5.8% |
| 2024-10-31 | pre | -2.6% | 2.6% | -5.8% | -6.5% |
Source filings
2026-08-04 · 8-K press release
1 - News Release Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline Sales Growth Ref
2026-04-30 · 8-K press release
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones Sales Growth Driven by Continued Strength in On
2026-02-03 · 8-K press release
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results ; Highlights Progress Advancing Broad, Diverse Pipeline Reports Strength in Oncology and Animal Healt
2025-10-30 · 8-K press release
1 - News Release Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results - Total Worldwide Sales Were $17.3 Billion, an Increase of 4% From Third Quarter 2024; Excluding th
2025-07-29 · 8-K press release
1 - News Release Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results - Total Worldwide Sales Were $15.8 Billion, a Decrease of 2% From Second Quarter 2024 Both Nominal
2025-04-24 · 8-K press release
Merck Announces First-Quarter 2025 Financial Results - Total Worldwide Sales Were $15.5 Billion, a Decrease of 2% From First Quarter 2024; Excluding the Impact of Foreign Exchange, Sales Grew 1% o KEY
2025-02-04 · 8-K press release
Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results - Fourth-Quarter Worldwide Sales Were $15.6 Billion, an Increase of 7% From Fourth Quarter 2023; Excluding the Impact of Foreign Exc
2024-10-31 · 8-K press release
Merck Announces Third-Quarter 2024 Financial Results - Total Worldwide Sales Were $16.7 Billion, an Increase of 4% From Third Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 7% o KE